Skip to content
healthcare.dev

BASAGLAR KwikPen

NDC 0002-7715, Insulin glargine, injection, solution, from Eli Lilly and Company.

Product NDC
0002-7715
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA205692
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7715 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0002-7715-59000027715595 SYRINGE in 1 CARTON (0002-7715-59) / 3 mL in 1 SYRINGE (0002-7715-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae
  • NADAC price for package 00002771559

    GET /v1/drugs/nadac/00002771559

Use it

Look up 0002-7715 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7715 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-7715. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.